-
Study aim
-
Comparing the effects of remifentanil with fentanyl on pain intensity, hemodynamic status and post-anesthesia complications of cataract surgery candidate
-
Design
-
This study will be conducted as a randomized clinical trial (blocks of four), double-blind, with parallel groups, without a control group, and phase 2-3, with the participation of 80 patients.
-
Settings and conduct
-
This study is a randomized clinical trial (blocks of four), double-blind (participants and results analyzer), with parallel groups, without a control group and phase 2-3 and with the participation of 80 ERCP candidates referred to Imam Reza Hospital (Tabriz) will be done.
-
Participants/Inclusion and exclusion criteria
-
The criteria for entering the study include: ASA class I and II , candidates for cataract surgery and consent to participate in the study, and the exclusion criteria are: having diabetes or other endocrine disorders and using painkillers in the last 24 hours.
-
Intervention groups
-
In the fentanyl group (group B), induction with 1 mg of midazolam, 0.7 micrograms per kilogram of body weight of fentanyl, 1 to 2 mg per kilogram of body weight of propofol along with 1 mg per kilogram of the patient's body weight Lidocaine and finally 10 mg of atracurium will be injected. In the remifentanil group (group A), induction with 1 mg of midazolam, 2 to 4 micrograms per kilogram of body weight of remifentanil, 1 to 2 mg per kilogram of body weight of propofol along with 1 mg per kilogram of body weight Lidocaine will be injected into the patient's body. Then, the speed of the onset of anesthesia and the complications after the surgery will be recorded in recovery.
-
Main outcome variables
-
Pain